BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33667681)

  • 1. Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking.
    Conde Penedo A; Díaz Tomé V; Fernández Ferreiro A; González Barcia M; Otero Espinar FJ
    Eur J Pharm Biopharm; 2021 May; 162():12-22. PubMed ID: 33667681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crown Ethers: Novel Permeability Enhancers for Ocular Drug Delivery?
    Morrison PWJ; Porfiryeva NN; Chahal S; Salakhov IA; Lacourt C; Semina II; Moustafine RI; Khutoryanskiy VV
    Mol Pharm; 2017 Oct; 14(10):3528-3538. PubMed ID: 28825493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability.
    Morrison PW; Connon CJ; Khutoryanskiy VV
    Mol Pharm; 2013 Feb; 10(2):756-62. PubMed ID: 23294178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal absorption of a new riboflavin-nanostructured system for transepithelial collagen cross-linking.
    Bottos KM; Oliveira AG; Bersanetti PA; Nogueira RF; Lima-Filho AA; Cardillo JA; Schor P; Chamon W
    PLoS One; 2013; 8(6):e66408. PubMed ID: 23785497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of hydroxypropyl beta-cyclodextrin on the corneal permeation of pilocarpine.
    Aktaş Y; Unlü N; Orhan M; Irkeç M; Hincal AA
    Drug Dev Ind Pharm; 2003 Feb; 29(2):223-30. PubMed ID: 12648019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transepithelial Riboflavin Absorption in an Ex Vivo Rabbit Corneal Model.
    Gore DM; O'Brart D; French P; Dunsby C; Allan BD
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):5006-11. PubMed ID: 26230765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Different Corneal Iontophoresis Protocols for Promoting Transepithelial Riboflavin Penetration.
    Gore DM; O'Brart DP; French P; Dunsby C; Allan BD
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7908-14. PubMed ID: 26670827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating in vivo delivery of riboflavin with coulomb-controlled iontophoresis for corneal collagen cross-linking: a pilot study.
    Arboleda A; Kowalczuk L; Savoldelli M; Klein C; Ladraa S; Naud MC; Aguilar MC; Parel JM; Behar-Cohen F
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2731-8. PubMed ID: 24667860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast-dissolving ocular films of riboflavin acetate conjugate for treatment of keratoconus in UVA-CXL procedure: ex vivo permeation, hemolytic toxicity and apoptosis detection.
    Tiwari A; Gangwar NK; Pathak K
    Expert Opin Drug Deliv; 2014 Mar; 11(3):325-43. PubMed ID: 24386903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riboflavin osmolar modification for transepithelial corneal cross-linking.
    Raiskup F; Pinelli R; Spoerl E
    Curr Eye Res; 2012 Mar; 37(3):234-8. PubMed ID: 22335811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracorneal melatonin delivery using 2-hydroxypropyl-β-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2.
    Ahn JH; Kim HD; Abuzar SM; Lee JY; Jin SE; Kim EK; Hwang SJ
    Int J Pharm; 2017 Aug; 529(1-2):608-616. PubMed ID: 28694094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transepithelial riboflavin/ultraviolet. a corneal cross-linking in keratoconus: morphologic studies on human corneas.
    Mencucci R; Paladini I; Sarchielli E; Favuzza E; Vannelli GB; Marini M
    Am J Ophthalmol; 2013 Nov; 156(5):874-884.e1. PubMed ID: 23972311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of corneal permeation of riboflavin-5'-phosphate through vitamin E TPGS: a promising approach in corneal trans-epithelial cross linking treatment.
    Ostacolo C; Caruso C; Tronino D; Troisi S; Laneri S; Pacente L; Del Prete A; Sacchi A
    Int J Pharm; 2013 Jan; 440(2):148-53. PubMed ID: 23046664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corneal cross-linking with hypo-osmolar riboflavin solution for keratoconus with thin corneas].
    Raiskup F; Kissner A; Spoerl E; Pillunat LE
    Ophthalmologe; 2011 Sep; 108(9):846-51. PubMed ID: 21858523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of in vivo iontophoresis-assisted corneal collagen cross-linking for keratoconus: An immunohistochemical study.
    Manetti M; Favuzza E; Sgambati E; Mencucci R; Marini M
    Acta Histochem; 2017 Apr; 119(3):343-347. PubMed ID: 28215504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomechanical Strengthening of the Human Cornea Induced by Nanoplatform-Based Transepithelial Riboflavin/UV-A Corneal Cross-Linking.
    Labate C; Lombardo M; Lombardo G; De Santo MP
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):179-184. PubMed ID: 28114577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models.
    Abdelkader H; Ismail S; Hussein A; Wu Z; Al-Kassas R; Alany RG
    Int J Pharm; 2012 Aug; 432(1-2):1-10. PubMed ID: 22575752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of various compositions of riboflavin eye drops on the intraoperative corneal thickness during UVA-cross-linking in keratoconus eyes].
    Vetter JM; Tubic-Grozdanis M; Faust M; Lorenz K; Gericke A; Stoffelns BM
    Klin Monbl Augenheilkd; 2011 Jun; 228(6):509-14. PubMed ID: 21656433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ophthalmic Econazole Hydrogels for the Treatment of Fungal Keratitis.
    Díaz-Tomé V; Luaces-Rodríguez A; Silva-Rodríguez J; Blanco-Dorado S; García-Quintanilla L; Llovo-Taboada J; Blanco-Méndez J; García-Otero X; Varela-Fernández R; Herranz M; Gil-Martínez M; Lamas MJ; González-Barcia M; Otero-Espinar FJ; Fernández-Ferreiro A
    J Pharm Sci; 2018 May; 107(5):1342-1351. PubMed ID: 29305870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.